Filing Flows

Filing Flows › Agenus (AGEN) › Q1 2025

Agenus (AGEN) Q1 2025 earnings results (first quarter 2025)

10-Q filed May 12, 2025

Agenus (AGEN) reported revenue of $24.1M for the first quarter 2025 (Q1 2025), -14% from a year earlier and -10% from the quarter before. Operating margin was -55.3%, net loss $26.4M (109.6% of revenue).

Revenue$24.1M
Year over year-14%
Quarter over quarter-10%
Operating margin-55.3%
Net earnings−$26.4M

Agenus, Q1 2025: revenue $24.1M (-14% year over year), operating margin -55.3%, net loss $26.4M, operating cash flow −$25.6M. The chart follows the revenue to costs, profit and cash.

Q1 2025AmountQ/QY/Y
Revenue$24.1M-10%-14%
Operating profit−$13.3M——
Net earnings−$26.4M——
Operating cash flow−$25.6M——

What changed

Revenue was $24.1M in Q1 2025, down 14% year over year and down 10% from the previous quarter. Non Cash Royalty Revenue Related to the Sale of Future Royalties was the largest line at 98% of revenue. Non Cash Royalty Revenue Related to the Sale of Future Royalties lost $4.2M year over year (down 15%), 107% of the total change.

Operating costs exceeded revenue by $13.3M, an operating margin of -55.3%. Total costs fell 39% while revenue fell 14%. The fastest-growing cost line was Cost of revenue (+28%). The quarter ended with a net loss of $26.4M, narrower than the previous quarter's $46.8M loss. Minority interests bore $1.1M of it: to shareholders the quarter was a loss of $25.3M.

Operating cash flow was −$25.6M. Non-cash charges added back $3.2M of depreciation and amortization and $3.5M of share-based compensation. Working capital and other items used $5.9M. Capital expenditures of $5K exceeded it, leaving free cash flow of −$25.6M.

Questions

What was Agenus' revenue in the first quarter 2025?

Agenus (AGEN) reported revenue of $24.1M for the first quarter 2025 (Q1 2025), -14% from a year earlier and -10% from the quarter before.

Was Agenus profitable in the first quarter 2025?

Operating loss was $13.3M (-55.3% of revenue) and net loss $26.4M.

Open the interactive Sankey →

Source: Agenus 10-Q on SEC EDGAR.